Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Жировая болезнь печени: новая номенклатура и ее адаптация в Российской Федерации. / Райхельсон, Карина Леонидовна; Маевская, М.В.; Жаркова, М. С.; Гречишникова, Василиса; Оковитый, Сергей Владимирович; Марченко, Наталья Валерьевна; Прашнова, Мария Константиновна; Деева, Т.А.; Ивашкин , Владимир Трофимович.
в: РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ, Том 34, № 2, 31.03.2024, стр. 35-44.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Жировая болезнь печени: новая номенклатура и ее адаптация в Российской Федерации
AU - Райхельсон, Карина Леонидовна
AU - Маевская, М.В.
AU - Жаркова, М. С.
AU - Гречишникова, Василиса
AU - Оковитый, Сергей Владимирович
AU - Марченко, Наталья Валерьевна
AU - Прашнова, Мария Константиновна
AU - Деева, Т.А.
AU - Ивашкин , Владимир Трофимович
N1 - Райхельсон К.Л., Маевская М.В., Жаркова М.С., Гречишникова В.Р., Оковитый С.В., Деева Т.А., Марченко Н.В., Прашнова М.К., Ивашкин В.Т. Жировая болезнь печени: новая номенклатура и ее адаптация в Российской Федерации. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2024;34(2):35-44. https://doi.org/10.22416/1382-4376-2024-961
PY - 2024/3/31
Y1 - 2024/3/31
N2 - Aim: localization of the new nomenclature of steatotic liver disease in Russian clinical practice. Key points. In 2023, international consensus decided to introduce a new nomenclature for steatotic liver disease. The article discusses the reasons for the change in nomenclature and the new terms adopted: steatotic liver disease, metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and alcohol associated steatotic liver disease. Adapting new terms to Russian healthcare poses a certain problem. The results of voting by Russian doctors on the introduction of new terms and their optimal translation are presented. A comparison of existing classifiers with new terms was carried out and the formulation of diagnoses was discussed taking into account the new nomenclature. Conclusions. Adaptation and implementation of new nomenclature into clinical practice is an important and complex task, in which it is necessary to maintain a balance between a progressive concept and the interests of practical healthcare.
AB - Aim: localization of the new nomenclature of steatotic liver disease in Russian clinical practice. Key points. In 2023, international consensus decided to introduce a new nomenclature for steatotic liver disease. The article discusses the reasons for the change in nomenclature and the new terms adopted: steatotic liver disease, metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and alcohol associated steatotic liver disease. Adapting new terms to Russian healthcare poses a certain problem. The results of voting by Russian doctors on the introduction of new terms and their optimal translation are presented. A comparison of existing classifiers with new terms was carried out and the formulation of diagnoses was discussed taking into account the new nomenclature. Conclusions. Adaptation and implementation of new nomenclature into clinical practice is an important and complex task, in which it is necessary to maintain a balance between a progressive concept and the interests of practical healthcare.
KW - alcohol associated steatotic liver disease
KW - metabolic dysfunction
KW - metabolic dysfunction-associated steatohepatitis
KW - metabolic dysfunction-associated steatotic liver disease
KW - non-alcoholic fatty liver disease
KW - steatotic liver disease
UR - https://www.mendeley.com/catalogue/5d5a1c73-1a95-38c9-93e6-1e59e5b3d79d/
U2 - 10.22416/1382-4376-2024-961
DO - 10.22416/1382-4376-2024-961
M3 - статья
VL - 34
SP - 35
EP - 44
JO - РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ
JF - РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ
SN - 1382-4376
IS - 2
ER -
ID: 120169964